Results: 4

Safety of incidental exposure to the novel oral poliovirus vaccine type 2 in pregnancy: A longitudinal observational study in Mozambique, 2022-2023

Vaccine; 15 (), 2024
To minimize the risk of vaccine-derived poliovirus emergences, the novel oral poliovirus vaccine type 2 (nOPV2), was bioengineered to have increased genetic stability compared to Sabin OPV and recommended for outbreak response Emergency Use Listing by WHO. Although pregnant women are not a target populat...

Scrutinizing human resources for health availability and distribution in Mozambique between 2016 and 2020: a subnational descriptive longitudinal study

Hum. resour. health; 21 (1), 2023
Introduction: Overall, resilient health systems build upon sufficient, qualified, well-distributed, and motivated health workers; however, this precious resource is limited in numbers to meet people's demands, particularly in LMICs. Understanding the subnational distribution of health workers from differ...

Vigilância Combinada de Factores de Risco e Doenças Não Transmissíveis em Moçambique: Estudos de Exequibilidade
Combined Surveillance of Risk Factors and Noncommunicable Diseases in Mozambique: Feasibility Studies

Introdução: A crescente carga global de Doenças Não Transmissíveis (DNTs) exige sistemas de vigilância que permitam acompanhar as tendências e avaliar o impacto de intervenções. O objectivo destes estudos foi testar modelos de vigilância hospitalar e comunitária de factores de risco e de DNTs....

Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries

Malar. j. (Online); 15 (43), 2016
Background: Dihydroartemisinin-piperaquine (DHA-PQ) is one of five WHO recommended artemisinin combination therapy (ACT) for the treatment of uncomplicated malaria. However, little was known on its post-registration safety and effectiveness in sub-Saharan Africa. DHA-PQ provides a long post-treatment pro...